fbpx
Home Tags George D. Yancopoulos

Tag: George D. Yancopoulos

Regeneron calculates $260M in 1Q antibody cocktail sales to government

Tarrytown-based Regeneron reports that it anticipates recording approximately $260 million in sales of its antiviral monoclonal antibody cocktail REGEN-COV U.S. to the U.S. government for the first quarter of 2021. Continuing deliveries...

Regeneron strikes deal with Roche on Covid cocktail

The cocktail is needed to both protect against being infected by the Covid-19 virus and also provide a treatment should infection occur.

Regeneron begins first human clinical trials of COVID-19 antibody ‘cocktail’

Regeneron this morning announced starting the first human clinical trial of a so-called “cocktail” of antibodies to fight COVID-19. The drug combination uses the...

Regeneron moves forward with two drugs against COVID-19

Regeneron has started a drug trial to see whether the drug Kevzara that it developed with the French multinational pharmaceutical company Sanofi and has...

Regeneron working on coronavirus treatment in Westchester labs

Tarrytown-based Regeneron and the U.S. Department of Health and Human Services (HHS) are working together in an effort to develop a treatment for the...

Regeneron co-founder talks drug process, importance of science

New York Medical College recently hosted a seminar featuring Dr. George D. Yancopoulos, founding scientist, president and chief scientific officer of the major biotech company.